Marker Therapeutics Inc (MRKR)

[undtrdr]

Some new coverage today

http://finance.yahoo.com/news/three-companies-ingredients-footsteps-advaxis-193300370.html

Another noteworthy company in the healthcare space, more specifically in the biotech space, is Taplmmune (TPIV). TPIV is also in the super-hot space of immunotherapy like Advaxis (ADXS). Being in the immuno-oncology space may be one of the main reasons for the stock's recent aggressive move upwards, but could also be attributed to some of the positive news the company has updated investors on upcoming phase II trials for their lead product(s) TPIV100/200. The Company's vaccine compositions, peptide or nucleic acid-based, comprise one or multiple naturally processed epitopes (NPEs) designed to comprehensively stimulate a patients’ killer T-cells, helper T-cells and to restore or further augment antigen presentation by the modulation of TAP (Transporter associated with Antigen Processing).